(Date:12/16/2009)... VEGAS, Dec. 16 Cord Blood America, ... blood stem cell preservation company ( http://www.cordblood-america.com ... of stem cells, a biological insurance policy, to ... has reduced its debt by a total of ... of 2009 and total debt eliminated for the ...
(Date:12/16/2009)... Sequenom, Inc. (Nasdaq: SQNM ), ... and Mr. David Pendarvis to its board of ... ,, Kenneth F. Buechler, Ph.D., was president, chief ... 1988 to 1994, Dr. Buechler was Biosite,s director ... was a senior research scientist for the diagnostics ...
(Date:12/16/2009)... HSP A has been found to be effectinve in improving yelds ... ... -- Nu-Tek BioSciences, LLC. ( www.nu-tekproducts.com ) is meeting the demand ... manufactured by Nutricepts, Inc. (Burnsville, Mn), is a high quality Soy ... HSP-A has been found to be especially effective in improving ...
(Date:12/15/2009)... Dec. 15 Repligen Corporation (Nasdaq: ... received $731,000 in research funding to support the ... from the Muscular Dystrophy Association (MDA). This ... toxicology testing and GMP manufacture of a drug ... the MDA not only provides important funding for ...
Breaking Biology Technology:Cord Blood America Says 2009 Debt Reduction Tops $10 Million 2Cord Blood America Says 2009 Debt Reduction Tops $10 Million 3Sequenom Appoints Two New Board Members 2Sequenom Appoints Two New Board Members 3Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3... by Mark Walton, Ph.D., President, ViaGen, January 11, ... the,European Food Safety Authority,s strong endorsement of the safety ... U.S. Food and Drug,Administration to release its final risk ... voluntary moratorium. The international,scientific consensus is clear: food from ...
... have developed the worlds first gene detection platform made ... in the January 11 issue of the journal Science, ... may also revolutionize the way in which gene expression ... starting with the most well-known structure in biology, DNA, ...
... BioCryst,Pharmaceuticals, Inc. (Nasdaq: BCRX ) today announced ... consultant and interim Chief Medical Officer. Dr.,Simon brings ... pharmaceutical,development to his position at BioCryst., (Logo: ... pleased to have Tom join BioCryst at this ...
Other Biology Technology:Statement on the Release of the European Food Safety Assessment on the Safety of Food Derived From Clones and Their Offspring in the Food Supply 2Nanotechnology innovation may revolutionize gene detection in a single cell 2Nanotechnology innovation may revolutionize gene detection in a single cell 3BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities 2BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities 3BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities 4SAIVI Alexa Fluor 680 injectable contrast agent *bovine serum albumin*...
Component of GELase Agarose Gel-Digesting Preparation. 1 ml of 50X Buffer is sufficient for replacing the buffer in at least 5 g of gel....
RABBIT ANTI QUINOLINIC ACID...
RAT ANTI MOUSE METALLOPHILIC MACROPHAGES...
Biology Products:Biology NavigationMedical Navigation